vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and BayCom Corp (BCML). Click either name above to swap in a different company.
BayCom Corp is the larger business by last-quarter revenue ($25.9M vs $21.2M, roughly 1.2× Autolus Therapeutics plc). BayCom Corp runs the higher net margin — 26.5% vs -373.3%, a 399.8% gap on every dollar of revenue. BayCom Corp produced more free cash flow last quarter ($30.1M vs $-72.3M).
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
BayCom Corp is a U.S.-headquartered bank holding company operating through its wholly owned subsidiary Bay Commercial Bank. It primarily serves small and medium-sized enterprises and retail customers across Northern California, offering commercial lending, deposit products, personal banking services, and localized wealth management solutions.
AUTL vs BCML — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $25.9M |
| Net Profit | $-79.1M | $6.9M |
| Gross Margin | — | — |
| Operating Margin | -337.9% | 36.6% |
| Net Margin | -373.3% | 26.5% |
| Revenue YoY | — | 9.4% |
| Net Profit YoY | 3.6% | 12.1% |
| EPS (diluted) | $-0.30 | $0.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $25.9M | ||
| Q3 25 | $21.2M | $25.7M | ||
| Q2 25 | $20.9M | $24.7M | ||
| Q1 25 | $9.0M | $24.3M | ||
| Q4 24 | — | $23.7M | ||
| Q3 24 | $0 | $25.6M | ||
| Q2 24 | $0 | $23.8M | ||
| Q1 24 | $10.1M | $24.5M |
| Q4 25 | — | $6.9M | ||
| Q3 25 | $-79.1M | $5.0M | ||
| Q2 25 | $-47.9M | $6.4M | ||
| Q1 25 | $-70.2M | $5.7M | ||
| Q4 24 | — | $6.1M | ||
| Q3 24 | $-82.1M | $6.0M | ||
| Q2 24 | $-58.3M | $5.6M | ||
| Q1 24 | $-52.7M | $5.9M |
| Q4 25 | — | 36.6% | ||
| Q3 25 | -337.9% | 26.3% | ||
| Q2 25 | -292.6% | 35.3% | ||
| Q1 25 | -726.3% | 31.6% | ||
| Q4 24 | — | 34.2% | ||
| Q3 24 | — | 32.4% | ||
| Q2 24 | — | 31.9% | ||
| Q1 24 | -384.1% | 33.3% |
| Q4 25 | — | 26.5% | ||
| Q3 25 | -373.3% | 19.5% | ||
| Q2 25 | -229.0% | 25.8% | ||
| Q1 25 | -781.1% | 23.4% | ||
| Q4 24 | — | 25.9% | ||
| Q3 24 | — | 23.5% | ||
| Q2 24 | — | 23.6% | ||
| Q1 24 | -522.1% | 24.0% |
| Q4 25 | — | $0.63 | ||
| Q3 25 | $-0.30 | $0.46 | ||
| Q2 25 | $-0.18 | $0.58 | ||
| Q1 25 | $-0.26 | $0.51 | ||
| Q4 24 | — | $0.55 | ||
| Q3 24 | $-0.31 | $0.54 | ||
| Q2 24 | $-0.22 | $0.50 | ||
| Q1 24 | $-0.24 | $0.51 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $265.5M | $338.6M |
| Total Assets | $661.9M | $2.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $86.1M | — | ||
| Q2 25 | $123.8M | — | ||
| Q1 25 | $95.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $657.1M | — | ||
| Q2 24 | $705.9M | — | ||
| Q1 24 | $758.5M | — |
| Q4 25 | — | $338.6M | ||
| Q3 25 | $265.5M | $334.3M | ||
| Q2 25 | $346.5M | $330.6M | ||
| Q1 25 | $371.1M | $329.3M | ||
| Q4 24 | — | $324.4M | ||
| Q3 24 | $477.0M | $321.7M | ||
| Q2 24 | $527.8M | $315.3M | ||
| Q1 24 | $582.0M | $314.2M |
| Q4 25 | — | $2.6B | ||
| Q3 25 | $661.9M | $2.6B | ||
| Q2 25 | $721.0M | $2.6B | ||
| Q1 25 | $746.3M | $2.6B | ||
| Q4 24 | — | $2.7B | ||
| Q3 24 | $827.5M | $2.6B | ||
| Q2 24 | $853.6M | $2.6B | ||
| Q1 24 | $901.4M | $2.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $31.8M |
| Free Cash FlowOCF − Capex | $-72.3M | $30.1M |
| FCF MarginFCF / Revenue | -341.2% | 116.2% |
| Capex IntensityCapex / Revenue | 20.8% | 6.7% |
| Cash ConversionOCF / Net Profit | — | 4.64× |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | $51.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $31.8M | ||
| Q3 25 | $-67.9M | $7.3M | ||
| Q2 25 | $-72.8M | $6.4M | ||
| Q1 25 | $-75.6M | $9.3M | ||
| Q4 24 | — | $30.4M | ||
| Q3 24 | $-76.7M | $9.6M | ||
| Q2 24 | $-51.1M | $7.7M | ||
| Q1 24 | $-40.5M | $5.1M |
| Q4 25 | — | $30.1M | ||
| Q3 25 | $-72.3M | $6.2M | ||
| Q2 25 | $-80.1M | $5.6M | ||
| Q1 25 | $-83.8M | $9.1M | ||
| Q4 24 | — | $28.7M | ||
| Q3 24 | $-86.3M | $9.4M | ||
| Q2 24 | $-51.9M | $7.4M | ||
| Q1 24 | $-41.0M | $3.9M |
| Q4 25 | — | 116.2% | ||
| Q3 25 | -341.2% | 24.3% | ||
| Q2 25 | -382.6% | 22.8% | ||
| Q1 25 | -933.1% | 37.6% | ||
| Q4 24 | — | 121.1% | ||
| Q3 24 | — | 36.6% | ||
| Q2 24 | — | 31.2% | ||
| Q1 24 | -406.8% | 16.1% |
| Q4 25 | — | 6.7% | ||
| Q3 25 | 20.8% | 4.3% | ||
| Q2 25 | 34.8% | 3.0% | ||
| Q1 25 | 91.8% | 0.6% | ||
| Q4 24 | — | 7.2% | ||
| Q3 24 | — | 1.0% | ||
| Q2 24 | — | 1.0% | ||
| Q1 24 | 5.3% | 4.7% |
| Q4 25 | — | 4.64× | ||
| Q3 25 | — | 1.47× | ||
| Q2 25 | — | 1.00× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 4.96× | ||
| Q3 24 | — | 1.60× | ||
| Q2 24 | — | 1.37× | ||
| Q1 24 | — | 0.86× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
